EXAGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.16 USD | +9.09% |
|
+14.29% | +8.54% |
| 14/05 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
| 13/05 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Healthcare Facilities & Services
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.75Cr | - | - | - | |||
| 8.35TCr | ||||||
| 2.67TCr | ||||||
| 1.81TCr | ||||||
| 1.82TCr | ||||||
| 1.65TCr |
- Stock Market
- Equities
- XGN Stock
- Charts Exagen Inc.
- Sector Chart
